Shots:

• The agreement includes drug for treatment of acne- fungal skin infections and rosacea- and a range of topical steroids summing up an annual turnover of ≥280 Mn Euros in 2017
•  Leo will have global product rights including sales- marketing in 14 countries except Afghanistan and Pakistan and a manufacturing site in Italy
• Acquisition closure will be during 2018 in the US and during H2’19 for RoW

Ref: Bayer | Image: Forbes